We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$35.5B
AUM Growth
+$586M
(+1.7%)
Cap. Flow
-$902M
Cap. Flow
% of AUM
-2.54%
Top 10 Holdings %
Top 10 Hldgs %
25.54%
Holding
2,317
New
189
Increased
687
Reduced
1,108
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
British American Tobacco
BTI
|
+$104M |
| 2 |
Occidental Petroleum
OXY
|
+$86.7M |
| 3 |
Canadian Imperial Bank of Commerce
CM
|
+$82.9M |
| 4 |
Public Storage
PSA
|
+$71.4M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$57.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$418M |
| 2 |
Consolidated Edison
ED
|
+$212M |
| 3 |
Crown Castle
CCI
|
+$103M |
| 4 |
Target
TGT
|
+$93.8M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 14.37% |
| 2 | Healthcare | 13.5% |
| 3 | Communication Services | 10.7% |
| 4 | Utilities | 9.74% |
| 5 | Technology | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
REVG
151
DELISTED
REV Group
REVG
| $40.3M | 0.11% |
1,240,000
+1,137,000
| +1,104% | +$31.2M |
|
152
Advanced Micro Devices
AMD
$715B
| $40M | 0.11% |
3,895,000
-11,788
| -0.3% | -$138K |
|
|
GWPH
153
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $39.4M | 0.11% |
298,200
+46,100
| +18% | +$5.42M |
|
154
Oracle
ORCL
$342B
| $39.2M | 0.11% |
828,553
+126,358
| +18% | +$6.2M |
|
155
HEICO Corp
HEI
$50.1B
| $39.2M | 0.11% |
810,889
+502
| +0.1% | +$23.4K |
|
|
XENT
156
DELISTED
Intersect ENT, Inc
XENT
| $39.2M | 0.11% |
1,208,797
+645
| +0.1% | +$19.3K |
|
157
FNB Corp
FNB
$6.78B
| $37.7M | 0.11% |
2,726,086
-20,171
| -0.7% | -$277K |
|
158
DXC Technology
DXC
$1.89B
| $37.7M | 0.11% |
458,749
-327,850
| -42% | -$26.5M |
|
159
Travelers Companies
TRV
$82.1B
| $37M | 0.1% |
273,146
-280,150
| -51% | -$37M |
|
160
Amgen
AMGN
$211B
| $36.8M | 0.1% |
211,580
+13,648
| +7% | +$2.42M |
|
161
L3Harris
LHX
$55.7B
| $36.5M | 0.1% |
257,880
-60,940
| -19% | -$8.51M |
|
162
Waste Management
WM
$95.8B
| $36.2M | 0.1% |
418,979
-115,750
| -22% | -$9.42M |
|
163
iShares Core MSCI Emerging Markets ETF
IEMG
$145B
| $35.7M | 0.1% |
627,111
+30,598
| +5% | +$1.71M |
|
164
Vail Resorts
MTN
$5.65B
| $35.5M | 0.1% |
167,155
+12,255
| +8% | +$2.74M |
|
165
Aflac
AFL
$65.8B
| $34.8M | 0.1% |
793,880
-221,486
| -22% | -$9.45M |
|
166
Cisco
CSCO
$450B
| $34.8M | 0.1% |
909,191
-566,633
| -38% | -$20.2M |
|
167
KLA
KLAC
$228B
| $34.8M | 0.1% |
3,307,660
-326,330
| -9% | -$3.44M |
|
168
Verisk Analytics
VRSK
$28.2B
| $34.8M | 0.1% |
362,002
+2,900
| +0.8% | +$262K |
|
|
WBA
169
DELISTED
Walgreens Boots Alliance
WBA
| $34.6M | 0.1% |
476,828
-91,528
| -16% | -$6.45M |
|
170
Radware
RDWR
$1.04B
| $34.6M | 0.1% |
1,781,650
| – | – |
|
171
Wingstop
WING
$3.77B
| $34.5M | 0.1% |
885,100
+500
| +0.1% | +$18.4K |
|
172
CVS Health
CVS
$136B
| $34.3M | 0.1% |
472,956
+100,569
| +27% | +$7.31M |
|
|
RP
173
DELISTED
RealPage, Inc.
RP
| $33.2M | 0.09% |
749,465
+72,768
| +11% | +$3.18M |
|
174
Citizens Financial Group
CFG
$30.5B
| $33.1M | 0.09% |
787,537
+24,032
| +3% | +$940K |
|
175
Rio Tinto
RIO
$153B
| $33.1M | 0.09% |
624,547
-47,096
| -7% | -$2.3M |
|
Similar funds
Federated Hermes's Q4 2017 Portfolio in Review
As of Q4 2017, Federated Hermes held 2,317 positions worth $35.5B, up 1.7% from $34.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Federated Hermes's Q4 2017 filing shows 189 new, 687 increased, 1,108 reduced and 152 closed positions. Its largest new stake was Azul: 1,190,200 shares worth $28.4M. The largest sale was AbbVie, an estimated $418M.
By sector, the portfolio is most concentrated in Consumer Staples at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Communication Services.
- Federated Hermes's largest Q4 2017 buy was Azul: 1,190,200 shares worth $28.4M.
- Federated Hermes added most to British American Tobacco in Q4 2017, an estimated $104M increase.
- Federated Hermes's biggest Q4 2017 reduction was AbbVie, cutting an estimated $418M.
- Federated Hermes fully exited iShares Biotechnology ETF in Q4 2017, selling an estimated $36.1M.
- Federated Hermes's ten largest holdings make up 26% of its $35.5B portfolio in Q4 2017.
- Federated Hermes opened 189 new positions and closed 152 in Q4 2017.
- Federated Hermes's portfolio value rose 1.7% quarter-over-quarter to $35.5B.
Based on Federated Hermes's 13F filing for Q4 2017, filed 14 Feb 2018.